Center for Scientific Review

File:US-NIH-CSR-Logo.svg

The Center for Scientific Review (CSR) is the portal for United States National Institutes of Health (NIH) grant applications and their review for scientific merit. The CSR organizes the peer review groups or study sections that evaluate the majority (76%) of the research grant applications sent to NIH.{{Cite web |title=CSR Data & Evaluations {{!}} NIH Center for Scientific Review |url=https://public.csr.nih.gov/AboutCSR/Evaluations |access-date=2024-07-29 |website=public.csr.nih.gov}} It also receives all grant applications for NIH, as well as for some other components of the United States Department of Health and Human Services (DHHS). Since 1946, its mission has remained clear and timely: to see that NIH grant applications receive fair, independent, expert, and timely reviews—free from inappropriate influences—so NIH can fund the most promising research.

CSR receives nearly 80,000 applications a year and recruits over 19,000 external experts{{Cite web |title=CSR Data & Evaluations {{!}} NIH Center for Scientific Review |url=https://public.csr.nih.gov/AboutCSR/Evaluations |access-date=2024-07-29 |website=public.csr.nih.gov}} to review its portion of them in its study sections, which often meet three times during the year. Additional scientists serve on other NIH advisory councils, which provide a second level of peer review and make funding recommendations based on priorities set by the United States Congress, DHHS, and the public.

From 1946 to 1997, the CSR was known as the Division of Research Grants (DRG).

Directors

Past directors from 1946 - present{{cite web|title=CSR Directors|url=https://www.nih.gov/about-nih/what-we-do/nih-almanac/center-scientific-review-csr|website=www.nih.gov|date=10 July 2015 }}

class=wikitable style="text-align:center"
{{abbr|No.|Number}}

!Portrait

!Director

!Took office

!Left office

!{{abbr|Refs.|References}}

1

|70px

|Cassius James Van Slyke

|January 1946

|December 1, 1959

|

2

|70px

|David E. Price MD

|1948

|1950

|

3

|70px

|Ernest M. Allen

|1951

|1960

|{{cite web |url=https://nihrecord.nih.gov/sites/nihrecord/files/pdf/1960/NIH-Record-1960-12-06.pdf |title=Dr. Burney Announces Top Level Changes in Grants Administration |date=December 6, 1960 |volume=12 |number=25 |page=1 |journal=The NIH Record}}

4

|70px

|Dale R. Lindsay

|1960

|1963

|

5

|70px

|Eugene A. Confrey

|October 1963

|1969

|{{cite web |url=https://nihrecord.nih.gov/sites/recordNIH/files/pdf/1963/NIH-Record-1963-10-22.pdf |title=Dr. Eugene A. Confrey Appointed DRG Chief |date=October 22, 1963 |volume=15 |number=21 |page=1 |journal=The NIH Record}}

6

|70px

|Stephen P. Hatchett

|May 1969

|August 22, 1976

|{{cite web |url=https://nihrecord.nih.gov/sites/recordNIH/files/pdf/1969/NIH-Record-1969-05-27.pdf |title=Dr. Hatchett Appointed Acting Director, DRG |date=May 27, 1969 |volume=21 |number=11 |page=3 |journal=The NIH Record}}{{cite web |url=https://nihrecord.nih.gov/sites/recordNIH/files/pdf/1976/NIH-Record-1976-09-08.pdf |title=Dr. Stephen P. Hatchett, Director of DRG Dies |date=September 8, 1976 |volume=28 |number=18 |page=1 |journal=The NIH Record}}

bgcolor="#e6e6aa"

|acting

|rowspan="2" bgcolor="#ffffff"|70px

|rowspan="2" bgcolor="#ffffff"|Carl D. Douglass

|August 1976

|April 1977

|

7

|April 1977

|May 3, 1985

|{{cite web |url=https://nihrecord.nih.gov/sites/recordNIH/files/pdf/1985/NIH-Record-1985-05-07.pdf |title=Dr. Carl Douglass, Director of DRG, Retires After 24 Years at NIH; Expanded Sections |date=May 7, 1985 |volume=37 |number=10 |page=11 |journal=The NIH Record}}

8

|70px

|Jerome G. Green

|January 1986

|June 1, 1995

|{{cite web |url=https://nihrecord.nih.gov/sites/recordNIH/files/pdf/1986/NIH-Record-1986-02-11.pdf |title=Dr. Jerome Green Named DRG Director |date=February 11, 1986 |volume=39 |number=3 |pages=1, 10 |journal=The NIH Record}}{{cite web |url=https://nihrecord.nih.gov/sites/recordNIH/files/pdf/1995/NIH-Record-1995-06-06.pdf |title=June 6, 1995 |volume=47 |number=12 |page=13 |journal=The NIH Record}}

9

|70px

|Ellie Ehrenfeld

|January 1, 1997

|September 30, 2003

|{{cite web |url=https://nihrecord.nih.gov/sites/recordNIH/files/pdf/1996/NIH-Record-1996-09-10.pdf |title=Ehrenfeld To Head DRG, Long-Time Grantee |first=Carla |last=Garnett |date=September 10, 1996 |volume=48 |number=19 |pages=1, 4 |journal=The NIH Record}}{{cite web |url=https://nihrecord.nih.gov/sites/recordNIH/files/pdf/2003/NIH-Record-2003-09-30.pdf |title=Ehrenfeld Resigns as CSR Director |date=September 30, 2003 |volume=55 |number=20 |page=5 |journal=The NIH Record}}

bgcolor="#e6e6aa"

|acting

|70px

|Brent Stanfield

|October 1, 2003

|June 30, 2005

|{{cite web |url=https://nihrecord.nih.gov/sites/recordNIH/files/pdf/2003/NIH-Record-2003-10-14.pdf |title=Stanfield Named Acting Director of CSR |date=October 14, 2003 |volume=60 |number=21 |page=16 |journal=The NIH Record}}

10

|70px

|Antonio Scarpa

|July 1, 2005

|September 2, 2011

|

bgcolor="#e6e6aa"

|acting

|rowspan="2" bgcolor="#ffffff"|70px

|rowspan="2" bgcolor="#ffffff"|Richard K. Nakamura

|September 18, 2011

|December 3, 2012

|{{cite web |url=https://nihrecord.nih.gov/sites/recordNIH/files/pdf/2011/NIH-Record-2011-10-14.pdf |title=Nakamura Named CSR’s Acting Director |date=October 14, 2011 |volume=63 |number=21 |page=11 |journal=The NIH Record}}

11

|December 3, 2012

|April 30, 2018

|{{cite web |url=https://nihrecord.nih.gov/sites/recordNIH/files/pdf/2013/NIH-Record-2013-01-04.pdf |title=Nakamura Named CSR Director |date=January 4, 2013 |volume=65 |number=1 |page=12 |journal=The NIH Record}}{{cite web |url=https://nihrecord.nih.gov/2018/06/01/csr-director-nakamura-retires |title=CSR Director Nakamura Retires |first=Don |last=Luckett |date=June 1, 2018 |volume=70 |number=11 |journal=The NIH Record}}

12

|70px

|Noni Byrnes

|February 14, 2019

|Present

|{{cite web |url=https://nihrecord.nih.gov/2019/03/08/byrnes-named-csr-director |title=Byrnes Named CSR Director |date=March 8, 2019 |volume=71 |number=5 |journal=The NIH Record}}

Current initiatives

  • Shorten the review process so applicants can revise and resubmit their applications in the next review round if necessary and NIH can more timely fund the best research. Shortening the review process by 45 days could thus reduce the time to resubmit by four months.
  • Recruit and retain the best reviewers so NIH and applicants receive the best advice.
  • Foster a culture more favorable to innovative applications, so that NIH can fund research that promises larger advances in science and health.
  • Address the concern that clinical research is not properly evaluated, so this important research is well represented in the NIH program.
  • Increase the transparency, accountability, and uniformity of NIH peer review.{{Cite web |url=http://cms.csr.nih.gov/AboutCSR/Welcome+to+CSR/ |title=Welcome to CSR |access-date=2007-06-25 |archive-url=https://web.archive.org/web/20070614141710/http://cms.csr.nih.gov/AboutCSR/Welcome+to+CSR/ |archive-date=2007-06-14 |url-status=dead }}

See also

References

{{reflist}}